Platelet Profile in Patients with Acute Bacterial Skin and Skin Structure Infections Receiving Tedizolid or Linezolid: Findings from the Phase 3 ESTABLISH Clinical Trials

Tedizolid, the active moiety of tedizolid phosphate, is a recently approved oxazolidinone antibacterial with activity against a wide range of Gram-positive pathogens, including resistant strains such as methicillin-resistant Staphylococcus aureus. To date, 6 days of 200 mg tedizolid once daily has b...

Full description

Saved in:
Bibliographic Details
Published in:Antimicrob Agents Chemother
Main Authors: Lodise, Thomas P., Fang, Edward, Minassian, Sonia L., Prokocimer, Philippe G.
Format: Artigo
Language:Inglês
Published: American Society for Microbiology 2014
Subjects:
Clinical Therapeutics
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4249542/
https://ncbi.nlm.nih.gov/pubmed/25246392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03509-14
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items